About
SEC Filings
Back


Form S-1/A
FIBROCELL SCIENCE, INC. filed this Form S-1/A on 11/17/2017
Document Outline
Entire Document (564.2 KB)
Subdocument 1 - S-1/A - S-1/A
Page 1 - As filed with the Securities and Exchange Commission on November 16, 2017
Page 2 - The information contained in this preliminary prospectus is not complete and may be changed. We may
Page 3 - TABLE OF CONTENTS
Page 4 - PROSPECTUS SUMMARY
Page 5 - Intrexon Collaborations
Page 6 - Phase 1/2 Clinical Trial of FCX-007 for RDEB
Page 7 - FCX-013 for Moderate to Severe Localized Scleroderma
Page 8 - New Gene Therapy Program for Arthritis and Related Conditions
Page 9 - Corporate Information
Page 10 - THE OFFERING
Page 11 - N/A
Page 12 - RISK FACTORS
Page 13 - Management will have broad discretion as to the use of the proceeds from this offering, and we may n
Page 14 - N/A
Page 15 - SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
Page 16 - N/A
Page 17 - SELECTED FINANCIAL DATA
Page 18 - Fibrocell Science, Inc.
Page 19 - Fibrocell Science, Inc.
Page 20 - USE OF PROCEEDS
Page 21 - MARKET PRICE OF OUR COMMON STOCK
Page 22 - CAPITALIZATION
Page 23 - N/A
Page 24 - DILUTION
Page 25 - N/A
Page 26 - DESCRIPTION OF CAPITAL STOCK
Page 27 - Voluntary Conversions by Holders.
Page 28 - Liquidation Preference.
Page 29 - No Exchange Listing of Preferred Shares.
Page 30 - Preferred Stock
Page 31 - Transfer Agent and Registrar
Page 32 - CERTAIN RELATIONSHIPS AND TRANSACTIONS WITH RELATED PERSONS
Page 33 - Registration Rights Agreement
Page 34 - PRINCIPAL STOCKHOLDERS
Page 35 - N/A
Page 36 - N/A
Page 37 - UNDERWRITING
Page 38 - Underwriter Warrants
Page 39 - Lock-up Agreements
Page 40 - Indemnification
Page 41 - LEGAL MATTERS
Page 42 - WHERE YOU CAN FIND MORE INFORMATION
Page 43 - 13,000,000 Shares
Page 44 - PART II
Page 45 - N/A
Page 46 - Item 15. Recent Sales of Unregistered Securities.
Page 47 - N/A
Page 48 - N/A
Page 49 - EXHIBIT INDEX
Page 50 - N/A
Page 51 - N/A
Page 52 - N/A
Page 53 - SIGNATURES
Subdocument 2 - EX-23.1 - EX-23.1
Page 1 - EXHIBIT 23.1



Printer Friendly Version E-mail this page RSS E-mail Alerts Download Financial Tear Sheet